Advertisement
Plenary Joint Session ERATS: Optimizing care in thoracic surgery – October 29, 2021 CO:22| Volume 35, SUPPLEMENT 1, S20, October 2021

ANATOMICAL INNERVATION AND PHARMACOLOGY OF INTERFASCIAL PLANE REGIONAL ANALGESIA FOR THORACIC SURGERY AND TRAUMA

      Introduction

      Opioid analgesia for thoracic surgery and trauma may be associated with adverse effects including respiratory depression, cough suppression and diminished consciousness. These adverse effects can be minimised using interfascial plane regional analgesia such as the erector spinae and serratus anterior plane blocks (ESPB and SAPB) as first described by Forero and colleagues and Blanco and colleagues, respectively.1,2 This systematic review aims to evaluate the anatomical evidence underlying innervation and dermatomal distribution of these two regional analgesic techniques. Additionally, the pharmacokinetics of ESPB and SAPB were compared.

      Methods

      Google Scholar, DiscoverEd, and PubMed were searched using key words: ESPB, SAPB, nerve block, local anaesthetic systemic toxicity, dermatomal spread, pharmacokinetics.

      Results

      The search yielded 39 papers investigating anatomical and pharmacokinetic evidence of which 11 were identified as relevant (Table 1). Table 1 found as an attachment
      Pharmacokinetic Results: The most commonly used local anaesthetic was bupivacaine and the use of adjuvants was infrequent. As proposed by Luftig and colleagues,3 a larger volume of a weaker concentration appears to reduce the chance of local anaesthetic systemic toxicity. Anatomical spread is dependent upon the dose and site of injection. Techniques can be easily taught and reproduced.

      Discussion

      The anatomical and pharmacokinetic evidence supports use of both techniques for thoracic regional analgesia with ESPB spreading more caudally than SAPB. However, there is anatomical variance between patients in the spread of each block. Pharmacokinetic evidence supports the use of low-concentration, high-volume local anaesthetic for optimal efficacy and limited toxicity.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Cardiothoracic and Vascular Anesthesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect